drugset / Trial / NCT02325310

Summary

In order to assess the safety of breastfed infants after their mother's postpartum immunization with a combined measles-mumps-rubella (MMR) vaccine, the purpose of this study is to investigate whether measles vaccine strain is excreted in breast milk of breastfeeding women with negative rubella and measles serologies.

Timeline

Start
2015-02-04
Primary completion
2016-05-03
Completion
2017-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Priorix Vaccine 0.5 ml Intramuscular